Centre for Information Resilience Warns of Mounting Disinformation Campaign in the Arab World and Across Africa
An Exclusive Agreement for the Commercialization of Multiple Biosimilars is Signed by Bioventure, Minapharm Pharmaceuticals, and MiGenTra